References (Harvard System)

1. Carlson JJ, Farquhar JW, Dinucci E, Ausserer L, Zehnder J, Miller D, Berra K, Hagerty L and Haskell WL, 2007, Safety and efficacy of a ginkgo biloba-containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitively intact older adults. J Am Diet Assoc, Vol. 107, pp 422432. 2. Dugoua JJ, Mills E, Perri D and Koren G, 2006, Safety and efficacy of ginkgo (Ginkgo biloba) during pregnancy and lactation, Can J Clin Pharmacol, Vol. 13, pp 277284. 3. Dutta-Roy AK, Gordon J, Kelly C, Hunter K, Crosbie L, Carpentar TK and Williams BC, 1999, Inhibitory effect of Ginkgo biloba extract on human platelet aggregation. Platelets, Vol. 10, pp 298305. 4. Gardner CD, Zehnder JL, Rigby AJ, Oliveira BM, Nicholus JR and Lal D, 2007, Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial, Blood Coagul Fibrinolysis, Vol. 18, pp 787793. 5. Gaudineau C, Beckerman R, Welbourn S and Auclair K, 2004, Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract, Biochem Biophys Res Comm; Vol. 31, Edn. 8, pp 10721078. 6. Hauser D, Gayowski T and Singh N, .2002, Bleeding complications precipitated by unrecognized Ginkgo biloba use after liver transplantation, Transpl Int, Vol. 15, pp 377 379. 7. Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, Day RO and McLachlan AJ, 2005, Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol, Vol. 59, pp 425 432. 8. Kohler S, Funk P and Kieser M, 2004, Influence of a 7-day treatment with ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in healthy volunteers, Blood Coagul Fibrinolysis, Vol. 15, pp 303309. 9. Kudolo GB, 2000, The effect of 3-month ingestion of Ginkgo biloba extract on pancreatic beta-cell function in response to glucose loading in normal glucose tolerant individuals, J Clin Pharmacol, Vol. 40, pp 647654. 10. Leistner E and Drewke C., 2010, Ginkgo biloba and ginkgotoxin., J Nat Prod, Vol. 73, pp 8692. 11. Yale SH and Glurich I, 2005 Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoarepens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9. J Alt Comp Med, Vol. 11, Edn.3, pp 433439. 12. Yin OQ, Tomlinson B and Waye MM, 2004, Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole, Pharmacogenetics, Vol. 14, Edn. 12, pp 841850.